Atorvastatin EP Impurity F

CAS No :

887196-24-9 (acid) ; 1105067-87-5

Molecular Formula:

C40H47FN3NaO8

Molecular Weight:

739.8

Chemical Name:

(3R,5R)-7-[(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanamido]-3,5-dihydroxyheptanoic acid Sodium salt

Add to Enquiry Basket
Product Enquiry

Related Products

Atorvastatin EP Impurity I

CAS No: ​125971-95-1

Molecular Formula:​ C40H47FN2O5

Molecular Weight: ​654.81

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity N

CAS No: ​134395-00-9

Molecular Formula:​ C37H43FN2O5

Molecular Weight: ​614.9

Inv. Status:​


Add to Enquiry Basket

Atorvastatin Difluoro Impurity

CAS No: ​693793-82-7

Molecular Formula:​ C26H23F2NO3

Molecular Weight: ​435.47

Inv. Status:​


Add to Enquiry Basket

Atorvastatin Epoxy Pyrrolooxazin 7-Hydroxy Analog

CAS No: ​1315629-79-8 (KLS-A06002)

Molecular Formula:​ C33H35FN2O7

Molecular Weight: ​556.6

Inv. Status:​


Add to Enquiry Basket

Atorvastatin Acid Isopropyl Ester

CAS No: ​ 1035205-25-4

Molecular Formula:​ C36H41FN2O5

Molecular Weight: ​600.7

Inv. Status:​


Add to Enquiry Basket

Difluoro Atorvastatin Acetonide tert-Butyl Ester

CAS No: ​693793-87-2

Molecular Formula:​ C40H46F2N2O5

Molecular Weight: ​672.8

Inv. Status:​


Add to Enquiry Basket

Atorvastatin 2,3,4,5-Dianhydro Acid

CAS No: ​2588261-49-6

Molecular Formula:​ C33H31FN2O3

Molecular Weight: ​522.6

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity C

CAS No: ​693793-53-2

Molecular Formula:​ C33H34F2N2O5 : Ca

Molecular Weight: ​576.6 : 1/2(40.1)

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity J

CAS No: ​1105067-93-3

Molecular Formula:​ C33H32FN2NaO4

Molecular Weight: ​562.61

Inv. Status:​


Add to Enquiry Basket

API – Impurities | Specialty Chemicals

Dribbble Pinterest

About

Kemiezen Lifesciences is established with a zeal of support the world with the best chemistry solutions with a group of dedicated scientists having 15 years of experience in the pharmaceutical industry.

Contact Us